ArticleBrain tumor pathology2026

Ataxin-2 as a candidate blood biomarker for estimating disease status in cases of suspected glioblastoma recurrence.

Farida Garaeva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.